TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza.

Seizaburo Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.